Glass House Brands (GLAS) Beginning Cash Balance (2020 - 2023)
Glass House Brands (GLAS) posted quarterly Beginning Cash Balance of $16.4 million for Q2 2023, down 34.09% year-over-year from $24.8 million in Q2 2022, and up 15.72% quarter-over-quarter from $14.1 million in Q1 2023.
Glass House Brands (GLAS) Beginning Cash Balance (2020 - 2023) Analysis & Trends
Glass House Brands (GLAS) has reported Beginning Cash Balance for 4 consecutive years, with $16.4 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Beginning Cash Balance fell 34.09% year-over-year to $16.4 million; the TTM figure through Jun 2023 stood at $72.9 million (down 100.0% YoY), while the FY2022 annual figure was $17.5 million, up 286.66% from the prior year.
- Beginning Cash Balance advanced to $16.4 million in Q2 2023 per GLAS's latest filing, from $14.1 million in the prior quarter.
- Across five years, Beginning Cash Balance topped out at $4535.3 billion in Q3 2021 and bottomed at $2.6 million in Q1 2020.
- Historically, Beginning Cash Balance has averaged $1170.3 billion across 4 years, with a median of $21.2 million in 2022.
- On a YoY basis, Beginning Cash Balance climbed as much as 1092.15% in 2022 and fell as far as 100.0% in 2022.
- Glass House Brands' Beginning Cash Balance stood at $2631.9 billion in 2020, then jumped by 72.32% to $4535.3 billion in 2021, then slumped by 100.0% to $17.5 million in 2022, then fell by 6.66% to $16.4 million in 2023.
- Business Quant data shows GLAS's Beginning Cash Balance at $16.4 million in Q2 2023, $14.1 million in Q1 2023, and $17.5 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Glass House Brands | 837.25 Mn | 818.69 Mn | 15.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 16.37 Mn |
| Jun 30, 2023 | 16.37 Mn |
| Mar 31, 2023 | 14.14 Mn |
| Mar 31, 2023 | 14.14 Mn |
| Dec 31, 2022 | 17.54 Mn |
| Dec 31, 2022 | 17.54 Mn |
| Jun 30, 2022 | 24.83 Mn |
| Jun 30, 2022 | 24.83 Mn |
| Mar 31, 2022 | 54.07 Mn |
| Mar 31, 2022 | 54.07 Mn |
| Dec 31, 2021 | 4,535.25 Bn |
| Dec 31, 2021 | 4,535.25 Bn |
| Sep 30, 2021 | 4,535.25 Bn |
| Sep 30, 2021 | 4,535.25 Bn |
| Mar 31, 2021 | 4.54 Mn |
| Mar 31, 2021 | 4.54 Mn |
| Dec 31, 2020 | 2,631.89 Bn |
| Dec 31, 2020 | 2,631.89 Bn |
| Mar 31, 2020 | 2.63 Mn |
| Mar 31, 2020 | 2.63 Mn |